The detection of psilocybin, the psychoactive compound in hallucinogenic mushrooms, via hair follicle drug testing is a complex issue. Standard drug screenings are typically designed to identify substances like opioids, cocaine, amphetamines, and marijuana. The presence of psilocybin is not routinely screened for in standard panels.
The relatively short window of time during which psilocybin remains detectable in the body, combined with its rapid metabolism, presents challenges for detection methodologies. Hair follicle testing offers a longer detection window compared to urine or blood tests, potentially spanning several months. However, the viability of detecting psilocybin specifically relies on the sensitivity of the testing method and whether the laboratory is specifically looking for the compound.